explore -WSS

explore

author：leisure time 2025-10-06 10:22:45 - browse：53888

An illustrated portrait of Eli Lilly's David Ricks and Skovronsky – biotech and pharma coverage from STAT — Eli Lilly CEO David Ricks (left) and Chief Scientific Officer Daniel S. Skovronsky Molly Ferguson for STAT

The partnership that would shape Eli Lilly into one of the biggest success stories in the pharmaceutical industry began with conversations around a relatively minor acquisition.

At the time, David Ricks was running Lilly’s U.S. business and was part of the team charged with evaluating Avid Radiopharmaceuticals, which Lilly would go on to purchase in 2010 for a paltry $300 million — couch change for a multibillion-dollar firm. But what struck Ricks was not the company’s technology, for imaging Alzheimer’s plaques, but Avid’s CEO, Daniel S. Skovronsky.

“Dan’s different,” Ricks told STAT. “I had this sense immediately. Some people get in biotech for the cha-ching.” Skovronsky turned out to be a secret weapon. Within six months, Ricks had been promoted to run Lilly’s biomedicine unit and Skovronsky was working for him.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Grail spinoff by Illumina should end disastrous merger attempt

WSS

In Spain, a hospital brews its own CAR

Intellia plays down concerns on accidental germline transmission

Hospital at home shows how to bring innovation to health care

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

FDA advisory panel to debate high blood pressure devices

Three trends to watch in biotech in 2024

entertainment

explore

Wikipedia

Dobbs anniversary: the lost opportunity of abortion as health care

Why health care costs have stayed mostly flat since 2010

In Memoriam: Notable people who died in 2023

Grail spinoff by Illumina should end disastrous merger attempt

Cancer drug shortages should be causing more outrage

CDC says it’s too soon to assess risk posed by Covid subvariant

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hospitals owned by private equity see complications spike 25%

Medical leaders decry Supreme Court decision on affirmative action

People can get long Covid without testing positive for virus: Study

leisure time

Carvykti CAR

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

People can get long Covid without testing positive for virus: Study

Can U.S. cancer drug shortages be fixed?

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Kellogg’s is going to war over Mexico’s nutrition label rules

knowledge

knowledge

knowledge

knowledge